JPMorgan Double Downgrades Dova Pharmaceuticals Inc (DOVA) to Underweight
Tweet
Share
E-mailGet Alerts DOVA Hot Sheet
Price: $28.04 --0%
Rating Summary:
4 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Rating Summary:
4 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 7
Join SI Premium – FREE
JPMorgan analyst Anupam Rama downgraded Dova Pharmaceuticals Inc (NASDAQ: DOVA) from Overweight to Underweight with a price target of $20.00 (from $34.00).
The analyst adjusts recommendations for US SMid names following the recent Healthcare Conference.
For an analyst ratings summary and ratings history on Dova Pharmaceuticals Inc click here. For more ratings news on Dova Pharmaceuticals Inc click here.
Shares of Dova Pharmaceuticals Inc closed at $7.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
- JPMorgan Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
- Freedom Broker Double Downgrades Mosaic (MOS) to Sell
Create E-mail Alert Related Categories
Analyst PT Change, Downgrades, Hot DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
